Stockreport

Vaccinex Reports 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

Vaccinex, Inc.  (VCNX) 
PDF Company raised $17.9 million of new financing during Q4 2023 and Q1 2024 ROCHESTER, N.Y., April 02, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical [Read more]